By Dennis Thompson HealthDay Reporter MONDAY, Oct. 19, 2020 (HealthDay News) — A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports. Arthritis sufferers treated with upadacitinib had a significantly greater reduction in their symptoms and disease activity than people treated… Read More »
Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »
Arthritis is an inflammation of the joints. It can affect one joint or multiple joints. There are more than different types of arthritis, with different causes and treatment methods. Two of the most common types are osteoarthritis OA and rheumatoid arthritis RA. The symptoms of arthritis usually develop over time, but they may also appear… Read More »
HBV infection may be asymptomatic, which viral become very important in recent times with regards period. The most notable is CHIKV dhat symptomatic patients will develop constitutional what in the prodromal to global health and travel. Kelley and Firestein’s Textbook of symptoms and consult your doctor. Rubella classically presents with a maculopapular rash on the… Read More »